Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Taiho Ventures, LLC Celebrates 10th Anniversary

prnewswire.com
JNJ LLY SNY RCUS

Smart Packaging and Electronic Patient Information Training Course: Overview of the Current Technologies, Patient and Societal Benefits and Building Blocks (ONLINE EVENT: May 21, 2026)

globenewswire.com
GSK AZN JNJ SNY

Francois Schramek Promoted to Partner at Manhattan West

prnewswire.com
AI AMN GM LMT NVDA GOOG MSFT SPCE RKLB GD BA AMD INTC META CRWD PLTR AN DD HON RTX IBM AMZN TSLA XOM CVX UNH BMY PFE MRK JNJ LLY GILD REGN BIIB AMGN AZN NVO SNY TEVA BABA JD NTES BIDU IQ VIPS BZUN HTHT MELI BBD BB ERIC NOK QCOM MU ADSK CRM GOOGL

Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type

globenewswire.com
SNY IMUX TLSA BIIB BMY TGTX

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

globenewswire.com
SNY REGN

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

globenewswire.com
REGN SNY

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight

globenewswire.com
EDSA VERU PLTR HLIO DRCT BHVN CART AMGN AROW AZN GSK NVS SNDX SNY UNH VRTX

Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month

globenewswire.com
AMGN BMY GSK JNJ REGN SNY PFE

$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics

globenewswire.com
PFE NVS SNY AZN

Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents

globenewswire.com
SNY